Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice

Abstract Statins are the cornerstone of therapy for individuals with hyperlipidemia. The aim of this study was to analyze the undesirable effects of mild, moderate and high doses of rosuvastatin in CD-1 male mice who received a cholesterol-rich diet, focusing on the morphological and functional chan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Juan C. Díaz-Zagoya, Alejandro Marín-Medina, Alma M. Zetina-Esquivel, Jorge L. Blé-Castillo, Andrés E. Castell-Rodríguez, Isela E. Juárez-Rojop, Rodrigo Miranda-Zamora
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/99bc8dd425344a31b26bced42afc131b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:99bc8dd425344a31b26bced42afc131b
record_format dspace
spelling oai:doaj.org-article:99bc8dd425344a31b26bced42afc131b2021-12-02T14:53:35ZEffects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice10.1038/s41598-021-95140-12045-2322https://doaj.org/article/99bc8dd425344a31b26bced42afc131b2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95140-1https://doaj.org/toc/2045-2322Abstract Statins are the cornerstone of therapy for individuals with hyperlipidemia. The aim of this study was to analyze the undesirable effects of mild, moderate and high doses of rosuvastatin in CD-1 male mice who received a cholesterol-rich diet, focusing on the morphological and functional changes on hepatocyte mitochondria. In a mouse model we studied the combined administration of a cholesterol-rich diet along with mild and moderate doses of rosuvastatin (1, 2.5 or 5 mg/kg/day) during several days. After the animals were sacrificed, liver mitochondria were isolated for microscopic studies and to analyze the respiratory function. The respiratory control (state-3/state-4) was evaluated in mice who received high doses of rosuvastatin. Rosuvastatin doses higher than 20 mg/kg/day induced premature death in mice with a hypercholesterolemic diet, but not in mice with a cholesterol-free diet. Doses from 2.5 to 5 mg/kg/day also induced morphological and functional alterations in mitochondria but these hypercholesterolemic animals survived longer. Giving 1 mg/kg/day, which is close to the maximal therapeutic dose for humans, did not affect mitochondrial architecture or respiratory function after two months of treatment. We analyzed the effect of rosuvastatin on hepatic tissue because it is where statins are mainly accumulated and it is the main site of endogenous cholesterol synthesis. Our results contribute to understand the side effects of rosuvastatin in hypercholesterolemic mice, effects that could also affect humans who are intolerant to statins.Juan C. Díaz-ZagoyaAlejandro Marín-MedinaAlma M. Zetina-EsquivelJorge L. Blé-CastilloAndrés E. Castell-RodríguezIsela E. Juárez-RojopRodrigo Miranda-ZamoraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Juan C. Díaz-Zagoya
Alejandro Marín-Medina
Alma M. Zetina-Esquivel
Jorge L. Blé-Castillo
Andrés E. Castell-Rodríguez
Isela E. Juárez-Rojop
Rodrigo Miranda-Zamora
Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
description Abstract Statins are the cornerstone of therapy for individuals with hyperlipidemia. The aim of this study was to analyze the undesirable effects of mild, moderate and high doses of rosuvastatin in CD-1 male mice who received a cholesterol-rich diet, focusing on the morphological and functional changes on hepatocyte mitochondria. In a mouse model we studied the combined administration of a cholesterol-rich diet along with mild and moderate doses of rosuvastatin (1, 2.5 or 5 mg/kg/day) during several days. After the animals were sacrificed, liver mitochondria were isolated for microscopic studies and to analyze the respiratory function. The respiratory control (state-3/state-4) was evaluated in mice who received high doses of rosuvastatin. Rosuvastatin doses higher than 20 mg/kg/day induced premature death in mice with a hypercholesterolemic diet, but not in mice with a cholesterol-free diet. Doses from 2.5 to 5 mg/kg/day also induced morphological and functional alterations in mitochondria but these hypercholesterolemic animals survived longer. Giving 1 mg/kg/day, which is close to the maximal therapeutic dose for humans, did not affect mitochondrial architecture or respiratory function after two months of treatment. We analyzed the effect of rosuvastatin on hepatic tissue because it is where statins are mainly accumulated and it is the main site of endogenous cholesterol synthesis. Our results contribute to understand the side effects of rosuvastatin in hypercholesterolemic mice, effects that could also affect humans who are intolerant to statins.
format article
author Juan C. Díaz-Zagoya
Alejandro Marín-Medina
Alma M. Zetina-Esquivel
Jorge L. Blé-Castillo
Andrés E. Castell-Rodríguez
Isela E. Juárez-Rojop
Rodrigo Miranda-Zamora
author_facet Juan C. Díaz-Zagoya
Alejandro Marín-Medina
Alma M. Zetina-Esquivel
Jorge L. Blé-Castillo
Andrés E. Castell-Rodríguez
Isela E. Juárez-Rojop
Rodrigo Miranda-Zamora
author_sort Juan C. Díaz-Zagoya
title Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
title_short Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
title_full Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
title_fullStr Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
title_full_unstemmed Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
title_sort effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/99bc8dd425344a31b26bced42afc131b
work_keys_str_mv AT juancdiazzagoya effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT alejandromarinmedina effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT almamzetinaesquivel effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT jorgelblecastillo effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT andresecastellrodriguez effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT iselaejuarezrojop effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
AT rodrigomirandazamora effectsofhighrosuvastatindosesonhepatocytemitochondriaofhypercholesterolemicmice
_version_ 1718389462046605312